Labopharm News
Most Popular Labopharm Story
Labopharm shares jump after FDA approves antidepressant
Shares of Canada's Labopharm jumped after the FDA announced it had approved the company's once-daily antidepressant trazodone after the drug was subjected to a delay. But CEO James Howard-Tripp tells Read more...
Latest Headlines
- August 17, 2011
- March 22, 2011
- February 3, 2010
- April 2, 2009
- June 30, 2008
- April 30, 2008
- January 24, 2008
- November 21, 2007
- September 28, 2006
- April 27, 2006
- April 11, 2006
- November 30, 2005
- September 8, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
